Treatment Goals for Primary Biliary Cholangitis, an Australian Perspective. [PDF]
Strasser SI +6 more
europepmc +1 more source
Combining bioinformatics and machine learning to analyze and validate sepsis-related cell senescence genes and potential drugs. [PDF]
Pei S +9 more
europepmc +1 more source
Fenofibrate restores glutamatergic and dopaminergic homeostasis in the nucleus accumbens and reduces alcohol relapse in rats. [PDF]
Isla E +8 more
europepmc +1 more source
Data Mining of the Japanese Adverse Drug Event Report Database and Animal Experiments for Assessment of Risks Associated With Pemafibrate. [PDF]
Kobuchi S +11 more
europepmc +1 more source
Clinical efficacy of combining fenofibrate with statins in patients with diabetes and hyperlipidemia: a meta-analysis. [PDF]
Huang J, Meng K, Qiu H.
europepmc +1 more source
Switching from Conventional Fibrates to Pemafibrate Improves Lipid Profiles, Liver Enzymes, Renal Function, and Fibrosis Markers in Dyslipidemic Patients with MASLD: A Multicenter Real-World Study. [PDF]
Sato T +10 more
europepmc +1 more source
Comparative efficacy and safety of ursodeoxycholic acid, fibrates, and combination therapy in primary biliary cholangitis: an umbrella meta-analysis of meta-analyses. [PDF]
Zhang J, Xiu T, Shen Q.
europepmc +1 more source
Plasma <sup>1</sup>H NMR-based metabolomic analysis reveals the lipid regulating effect of novel carboxamide derivatives in hyperlipidemic rats. [PDF]
Alwahsh M +6 more
europepmc +1 more source

